Septocoll E

Due to their favorable physical surface properties, collagen fleeces shorten the bleeding time and reduce blood loss. In contact with blood, collagen causes platelet aggregation. Large numbers of platelets accumulate on the collagen fleece and release coagulation factors. In conjunction with plasma factors these induce fibrinogenesis. They support the overall wound healing process by promoting rapid collagen and protein synthesis. The collagen used to manufacture SeptocollAR E is obtained only from equine tendons. TSE (Transmissible Spongiform Encephalopathy) does not occur in horses. Biological resorption of SeptocollAR E is complete after around four weeks. Additional surgery to remove the hemostatic material is not necessary.
Scope of application

SeptocollAR E is suitable for use in bone and soft-tissue surgery in all disciplines of septic and aseptic surgery. The application of SeptocollAR E can be recommended as a hemostat for:

a c Potentially contaminated wounds
a c Contaminated wounds
a c Revision operations in septic surgery

We have optimized the use of SeptocollAR E in surgical applications: The fleece does not stick to surgical instruments and can be handled, shaped and cut easily with precision.